Physician Wealth Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

Physician Wealth Advisors’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$504	Hold	1	–	–	﹤0.01%	2236
2026 Q2	$537	Sell	1 -1	-50%	-$512	﹤0.01%	2089
2026 Q1	$1.05K	Sell	2 -1	-33%	-$478	﹤0.01%	1661
2025 Q4	$1.75K	Buy	3 +2	+200%	+$1.02K	﹤0.01%	1351
2025 Q3	$459	Buy	+1	New	+$373	﹤0.01%	1845
2025 Q2	–	Sell	-2	Closed	-$663	–	1906
2025 Q1	$663	Buy	+2	New	+$657	﹤0.01%	1300

Other funds holding MDGL

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Physician Wealth Advisors's MDGL Position: Q3 2026 in Review

Physician Wealth Advisors held its Madrigal Pharmaceuticals (MDGL) position steady in Q3 2026 at 1 share worth $504. The position accounts for ﹤0.01% of the portfolio, ranked #2236.

Physician Wealth Advisors first reported a position in MDGL in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.75K in Q4 2025. 226 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.

Physician Wealth Advisors held 1 share of Madrigal Pharmaceuticals worth $504 as of Q3 2026.
Physician Wealth Advisors left its Madrigal Pharmaceuticals share count unchanged in Q3 2026.
Madrigal Pharmaceuticals made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q3 2026, its #2236 holding.
Physician Wealth Advisors first reported a position in Madrigal Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
Physician Wealth Advisors's Madrigal Pharmaceuticals position peaked at $1.75K in Q4 2025.
226 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.